Edward Parsons Email & Phone Number

Palm Beach Gardens, Fl / Needham, Ma

Evaluated clinical strategy and market opportunities for therapeutic programs in oncology and ophthalmology. Assisted in transition to phase 2 development of an oral drug for wet AMD, analysis and reporting of clinical results, and a follow-on financing process.

Palm Beach Gardens, Fl / Needham, Ma

Assisted analysis of clinical and market landscape for cancer therapeutic drugs, and with a diligence/financing process.

South San Francisco, Ca

Assisted in post-merger integration, the launch of a novel molecular diagnostic for lung cancer, and strategy for further development.

Maynard, Ma

Directing the development and launch of a molecular diagnostic for lung cancer. Responsible for marketing, clinical, regulatory, IP, and corporate financing strategy. Designed clinical validation studies; performed health economic analysis. Managed the merger of Allegro Diagnostics with Veracyte, Inc.

North Billerica, Ma

Advised Lantheus on the US market launch of an acquired product. Developed medical affairs/information system to support physicians, competitive positioning analysis, regulatory strategy, and lifecycle management. Developed sales training program, conducted scientific advisory boards, served as expert representative at FDA advisory panel.

Established, funded, and managed development companies for early-stage therapeutic products, in partnership with entrepreneurs, investors, and established pharmaceutical companies. Developed business models, strategies, and financial models; identified value propositions, market segments, and likely partners.

Cambridge, Ma

Assisted Fidelity’s healthcare venture capital group investing in medical devices, diagnostics, and therapeutics.

Lexington, Ma

Managed clinical and regulatory activities in support of targeted MRI contrast agents. Planned and implemented development pathway leading to the US-FDA approval of an imaging drug. Supported marketing of diagnostic imaging products in 32 countries. Assisted in new drug application (NDA) and investigational new drug (IND) submissions. Responsible for clinical research, academic and industrial research collaborations. Co-authored multinational phase 2 & 3 protocols, including technical and statistical design. Oversaw image evaluation and statistical analysis. Developed theory, preclinical imaging studies, and clinical applications of novel imaging agents. Designed clinical studies to accelerate the evaluation of efficacy in CNS and cardiovascular therapeutic drug programs. Completed ongoing competitive assessments of drugs in the pipeline. Contributed to business development and corporate partnering efforts.

Mba, Sloan Fellows Program In Innovation And Global Leadership

Studies concentrated in finance, entrepreneurship, and the healthcare industry in Sloan’s Program in Innovation and Global Leadership.

Phd, Ms, Applied Physics

Developed theory and techniques to study structure, function, metabolism, and underlying sources of MRI contrast. Taught coursework.

Bs, Applied Physics